Attached files
file | filename |
---|---|
EX-31.2 - EXHIBIT 31.2 - Altimmune, Inc. | v452140_ex31-2.htm |
EX-10.61 - EXHIBIT 10.61 - Altimmune, Inc. | v452140_ex10-61.htm |
10-Q/A - FORM 10-Q/A - Altimmune, Inc. | v452140_10qa.htm |
Exhibit 31.1
Certification of Principal Executive Officer
Pursuant to SEC Rule 13a-14(a)/15d-14(a)
I, John M. Gill, certify that:
1. | I have reviewed this Amendment No. 1 to the Quarterly Report on Form 10-Q/A of PharmAthene, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Dated: November 22, 2016 | /s/ John M. Gill |
Name: John M. Gill | |
Title: President and Chief Executive Officer |